FY 2020-2021SABG Report 8-2021 _

FY 2020-2021SABG Report 8-2021 _.docx

Community MH Services BG and SAPT BG Application Guidance and Instructions FY 2022-2023

FY 2020-2021SABG Report 8-2021 _

OMB: 0930-0168

Document [docx]
Download: docx | pdf












Shape1 Block Grant Reporting Section














CFDA 93.959

Substance Abuse Prevention and Treatment Block Grant

(SABG)









U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration


Table of Contents



  1. Introduction



  1. Annual Update

SABG Table 1 Priority Area and Annual Performance Indicators Progress Report


  1. State Agency Expenditure Reports

SABG Table 2 - State Agency Expenditure Report SABG Table 3 – Syringe Services Program

SABG Table 4 - SABG State Agency Expenditure Compliance Report SABG Table 5a - SABG Primary Prevention Expenditures Checklist

SABG Table 5b - SABG Primary Prevention Expenditures by IOM Category SABG Table 5c - SABG Primary Prevention Targeted Priorities

SABG Table 6 - Systems Development/Non-Direct Service Activities Expenditure Checklist SABG Table 7 - SABG Statewide Entity Inventory

SABG Table 8a - Maintenance of Effort for State Expenditures for Substance Abuse Prevention and Treatment

SABG Table 8b - Base and Maintenance of Effort for Expenditures for Services to Pregnant Women and Women with Dependent Children


  1. Population and Services Reports

SABG Table 9 - Prevention Strategy Report SABG Table 10 - Treatment Utilization Matrix

SABG Table 11 - Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use

SABG Table 12 - SABG HIV Early Intervention Services in Designated States SABG Table 13 - Charitable Choice


  1. Performance Data and Outcomes Treatment Performance Measures

SABG Table 14 - Employment/Education Status SABG Table 15 - Stability of Housing

SABG Table 16 - Criminal Justice Involvement SABG Table 17 -Change in Abstinence–Alcohol Use

SABG Table 18 - Change in Abstinence – Other Drug Use SABG Table 19 - Change in Social Support of Recovery

SABG Table 20 - Retention Prevention Performance Measures

SABG Table 21 - Reduced Morbidity–Abstinence from Drug Use/Alcohol Use; Measure: 30 Day Use

SABG Table 22 - Reduced Morbidity –Abstinence from Drug Use/Alcohol Use; Measure: Perception Of Risk/Harm of Use

SABG Table 23 - Reduced Morbidity–Abstinence from Drug Use/Alcohol Use; Measure: Age of First Use

SABG Table 24 - Reduced Morbidity–Abstinence from Drug Use/Alcohol Use; Measure: Perception of Disapproval/Attitudes

SABG Table 25 - Employment/Education; Measure: Perception of Workplace Policy

SABG Table 26 - Employment/Education; Measure: Average Daily School Attendance Rate SABG Table 27 - Crime and Criminal Justice; Measure: Alcohol-Related Traffic Fatalities SABG Table 28 - Crime and Criminal Justice; Measure: Alcohol and Drug Related Arrests SABG Table 29 - Social Connectedness; Measure: Family Communications around Drug and Alcohol Us

SABG Table 30 - Retention; Measure: Percentage of Youth Seeing, Reading, Watching, or Listening to a Prevention Message

SABG Table 31 - Individual-Based Programs and Strategies; Measure: Number of Persons Served By Age, Gender, Race, and Ethnicity

SABG Table 32 - Population-Based Programs and Strategies; Measure: Number of Persons Served By Age, Gender, Race, and Ethnicity

SABG Table 33 - Number of Persons Served by Type of Intervention

SABG Table 34 - Number of Evidence-Based Programs by Types of Intervention.

SABG Table 35 - Number of Evidence-based Programs and Strategies, and Total SA Block Grant Funds Spent on Evidence-Based Programs/ Strategies.







Section A. Introduction


Section 1942(a) of Title XIX, Part B, Subpart III of the Public Health Service Act (42 U.S.C. § 300x- 52(a)) requires the Secretary of the Department of Health and Human Services, acting through the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), to determine the extent to which states1 have implemented the State Plan for the preceding fiscal year. The purpose of the Substance Abuse Prevention and Treatment Block Grant (SABG) Annual Report is to provide information to assist the Secretary in making this determination.


States are required to prepare and submit an annual report that includes expenditure summaries for

(1) the state fiscal year (SFY) immediately preceding the federal fiscal year for which the state is applying for funds; and (2) the obligation and expenditure period of the Substance Abuse Prevention and Treatment Block Grant (SABG) Notice of Award (NoA) subject to CSAT compliance review (Compliance Award), in the format provided in this guidance. The SABG Annual Report will address the purposes for which the SABG funds were expended, the SABG sub-recipients, and the authorized activities funded and services purchased with such funds. Particular attention should be given to the progress made toward accomplishing the goals and performance indicators identified in the states’ and jurisdictions’ plans.

All States are required to prepare and submit their respective SABG Annual Reports utilizing SAMHSA’s Web Block Grant Application System (BGAS). Annual reports must be received by SAMHSA not later than December 1 in order for a state or jurisdiction to receive its fiscal year SABG NoA. If a receipt date falls on a weekend or federal holiday, the receipt date for a report will be the next business day. The following schedule provides specific due dates for the SABG Annual Reports, MHBG Implementation Reports and the Annual Synar Reports:


Due Dates for SA Only and MHBG/SABG Applications

FY for which the state

is applying for funds

Application

Due

Plan

Due

Planning Period

SABG Report

Due

Synar Report

Due

2020

9/3/2019

Yes

7/1/19 6/30/21

12/1/2019

Compliance Year is 2017

12/31/2019

2021

9/1/2020

No*

NA

12/1/2020

Compliance Year is 2018

12/31/2020




Receipt Dates for Reports

Applicable FY

SABG Annual Report

MHBG Implementation Report

Annual Synar Report

2020

12/01/2019

12/01/2019

12/31/2019

2021

12/01/2020

12/01/2020

12/31/2020


1 The term ”state” means each of the several states, the District of Columbia and each of the territories of the United States. The term “territories of the United States” means each of the Commonwealth of Puerto Rico, Virgin Islands, American Samoa, Commonwealth of the Northern Marianas Islands, Federated States of Micronesia, Guam, Republic of the Marshall Islands and the Republic of Palau

2 The term “substance use disorder “ means substance-related and addictive disorders as described in the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition, Arlington, VA, American Psychiatric Association, 2013.



States are required to prepare and submit an annual report comprised of the following sections:


Section B: Annual Update - In this section, states are required to provide a brief review of the extent to which their respective plans were implemented, and the progress toward the priorities and goals identified in the SABG plan covering SFY 2019 and 2020. The report should also include a brief review of areas that the state identified in that SABG plan as needing improvement and changes that the state or jurisdiction proposed to achieve the goals established for the priorities.


Section C: State Agency Expenditure Reports - In this section, states must provide information regarding expenditures for authorized activities and services for substance misuse prevention, substance use disorder2 (SUD) treatment and recovery. The state must provide a description of SABG expenditures for authorized activities to prevent substance misuse and treat SUDs and related services for tuberculosis, and, if it is a “designated State,” a description of SABG expenditures for early intervention services for regarding the human immunodeficiency virus (EIS/HIV). In addition, the state must identify the SABG expenditures made available to intermediaries, administrative service organizations, and community- and faith-based organizations that received amounts from the SABG to provide authorized activities to prevent and treat SUDs.


Section D: Populations and Services Reports - In this section, states must provide specific information regarding the number of individuals that were served with SABG funds. In addition, states should provide specific information regarding the services these individuals received.


Section E: Performance Indicators and Accomplishments - In this section of the report, states are required to complete the Performance Indicator tables. Performance indicators should be reported using the table format provided in this document. The purpose of the performance indicator tables is to show progress made over time as measured by SAMHSA’s National Outcome Measures (NOMS) for substance misuse prevention, SUD treatment and recovery.












  1. Annual Update


The information states entered into SABG Table 1 in the planning section of the 2020/2021 Behavioral Health Assessment and Plan will automatically populate cells 1 - 6 in the progress report table below. States are required to indicate whether each first-year performance target/outcome measurement identified in 6.b below (from the 202/2021 Plan) was “Achieved” or “Not Achieved” in Cell 7, Report of Progress toward Goal Attainment. If a target was not achieved, a detailed explanation must be provided, as well as the remedial steps proposed to meet the target.


SABG Table 1 - Priority Areas and Annual Performance Indicators Progress Report



Priority Areas and Annual Performance Indicators

1. Priority Area:

2. Priority Type (SAP, SAT, MHS):

3. Population(s) (SMI, SED, FEP, PWWDC, PP, PWID (formerly IVDUs), EIS/HIV, TB, OTHER):

4. Goal of the Priority Area:

5. Strategies to Attain the Goal:

6. Annual Performance Indicators to Measure Goal Success:

Indicator #1:


a) Baseline measurement (Initial data collected prior to the first-year target/outcome):

b) First-year target/outcome measurement (Progress end of SFY 2020):

c) Second-year target/outcome measurement (Final end of SFY 2021):

d) Data source:

e) Description of data:

f) Data issues/caveats that affect outcome measures:

7. Report of Progress toward Goal Attainment:

First-year target: Achieved Not Achieved (If not achieved, explain why.)

Reason why target was not achieved, and changes proposed to meet target:

  1. State Agency Expenditure Reports


States are required to provide information regarding SABG and state funds expended for authorized activities to prevent and treat SUDs and for related public health services, e.g., tuberculosis services (TB) and, if applicable, early intervention services regarding the human immunodeficiency virus (EIS/HIV). Please complete the tables described below:


SABG Table 2A - State Agency Expenditure Report This table provides a report of SABG, COVID-19, and state expenditures by the principal agency of a state, i.e., single state agency (SSA), during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. Expenditures to be reported are for authorized activities to prevent and treat SUDs pursuant to section 1921 of Title XIX, Part B, Subpart II of the Public Health Service (PHS) Act (42 U.S.C. § 300x-21); tuberculosis services; early intervention services regarding the human immunodeficiency virus (EIS/HIV), if applicable; pursuant to section 1924(b) of Title XIX, Part B, Subpart II of the PHS Act (42 U.S.C. § 300x-24(b)); and administration pursuant to section 1931(a)(2) of Title XIX, Part B, Subpart II of the PHS Act (42 U.S.C. § 300x-31(a)(2)). In column A, the applicable federal fiscal years’ SABG funds expended during the state fiscal year should be included.


SABG Table 2B – COVID-19 Relief Supplement Funds Expenditure by Service. This table provides a report of COVID-19 Relief Supplement expenditures for services to assist states in responding to the COVID-19 pandemic.

SABG Table 3 – Syringe Services Program This table provides a report of SABG and COVID expenditures for elements of syringe services programs carried out by SABG sub-recipients as described in the guidance disseminated by the Office of HIV/AIDS and Infectious Disease Policy, the Centers for Disease Control and Prevention, National Center on HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV Prevention and SAMHSA. The authorization to expend federal funds for elements of a syringe services program is subject to an authorization in the annual appropriations’ bill(s).

SABG Table 4 - SABG State Agency Expenditure Compliance Report This table provides a report of expenditures for authorized activities to prevent and treat SUDs associated with a SABG Notice of Award (NoA) for the applicable fiscal year. It covers the two-year obligation and expenditure period.

SABG Table 5a- SABG Primary Prevention Expenditures Checklist This table provides a report of primary prevention expenditures associated with a SABG NoA for the applicable fiscal year. It covers the two-year obligation and expenditure period. Table 5a excludes Expenditures for Systems Development/Non-Direct Service Activities (formerly known as Resource Development expenditures).

SABG Table 5b- SABG Primary Prevention Expenditures by IOM Category This table provides a report of primary prevention expenditures by Institute of Medicine (IOM) categories associated with a SABG NoA for the applicable fiscal year. It covers the two-year obligation and expenditure period. Table 5b excludes Expenditures for Systems Development/Non-Direct Service Activities (formerly known as Resource Development expenditures).

SABG Table 5c - SABG Primary Prevention Targeted Priorities This requested table provides a report of actual state primary prevention priorities and special population categories on which the state expended primary prevention funds from the SABG NoA for the applicable fiscal year.

SABG Table 6 – Expenditures for System Development/Non-Direct Service Activities This table provides a report of expenditures from the SABG and COVID-19 NoAs for system development and non-direct service activities that were supported by the SABG and COVID-19 awards. NoA for the applicable fiscal year.

SABG Table 7 – SABG Statewide Entity Inventory This table provides a report of the SABG sub- recipients including community- and faith-based organizations which provided SUD prevention activities and treatment services, as well as intermediaries/administrative service organizations. Table 7 excludes Expenditures for Systems Development/Non-Direct Service Activities (formerly known as Resource Development expenditures).

SABG Table 8a - Maintenance of Effort for State Expenditures for Substance Abuse Prevention and Treatment This table provides a report of aggregate state expenditures by the SSA for authorized activities to prevent and treat SUDs during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds.


SABG Table 8b - Base and Maintenance of Effort for Expenditures for Services to Pregnant Women and Women with Dependent Children This table provides a report of SABG and/or state funds pursuant to 42 U.S.C. § 300x-22(b) and 45 CFR § 96.124(c)(3) expended to establish new programs or expand the capacity of existing programs designed to serve pregnant women and women with dependent children and the services required pursuant to 45 CFR § 96.124(e) to address the treatment and recovery needs of such women during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds.

SABG Table 2 - State Agency Expenditure Report

This table provides a report of SABG and state expenditures by the SSA during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds for authorized activities to prevent and treat SUDs. For detailed instructions, refer to those in the Block Grant Application System (BGAS).



State Agency Expenditure Report


SABG Table 2A


State Identifier:


Report Period- From: To:


(Include ONLY funds expended by the executive branch agency administering the Substance Abuse Block Grant)


Source of Funds


ACTIVITY

(See instructions for using Row 1.)


A.

SABG

B.

MHBG

C.

Medicaid (Federal, State, and local)

D.

Other Federal Funds

(e.g., ACF

(TANF), CDC,

CMS (Medicare) SAMHSA, etc.)

E.

State funds

F.

Local funds (excluding local Medicaid)

G.

Other


H.

COVID-190

  1. Substance Abuse Prevention0 and Treatment









    1. Pregnant Women and Women with Dependent Children2








    1. All Other








  1. Primary Prevention








  1. Tuberculosis Services








  1. Early Intervention Services Regarding the Human Immunodeficiency Virus (EIS/HIV)0








  1. Administration (excluding program / provider level administration)








8. Total








Table 2b - COVID-19 Relief Supplemental Funds Expenditure by Service


Expenditure Period Start Date: 3/15/2021 Expenditure Period End Date: 9/30/2021



Shape2

8. TotalService

Expenditures

Healthcare Home/Physical Health

$

Specialized Outpatient Medical Services


Acute Primary Care


COVID-19 Screening (e.g., temperature checks, symptom questionnaires)


COVID-19 Testing


COVID-19 Vaccination


Comprehensive Care Management


Care Coordination and Health Promotion


Comprehensive Transitional Care


Individual and Family Support


Referral to Community Services Dissemination


Prevention (Including Promotion)


Screening with Evidence-based Tools


Risk Messaging


Access Line/Crisis Phone Line/Warm Line


Purchase of Technical Assistance


COVID-19 Awareness and Education for Person with SUD


Media Campaigns (Information Dissemination)


Employee Assistance Programs (Problem Identification and Referral)


Intervention Services


Fentanyl Strips


Syringe Services Program


Naloxone


Overdose Kits/Dissemination of Overdose Kits


Engagement Services


Assessment


Specialized Evaluations (Psychological and Neurological)


Services Planning (including crisis planning)


Consumer/Family Education


Outreach (including hiring of outreach workers)


Outpatient Services


Evidence-based Therapies


Group Therapy


Family Therapy


Multi-family Therapy


Consultation to Caregivers


Medication Services


Medication Management


Pharmacotherapy (including MAT)


Laboratory Services


Community Support (Rehabilitative)


Parent/Caregiver Support


Case Management


Behavior Management


Supported Employment


Permanent Supported Housing


Recovery Housing


Recovery Supports


Peer Support


Recovery Support Coaching


Recovery Support Center Services


Supports for Self-Directed Care


Supports (Habilitative)


Personal Care


Respite


Supported Education


Acute Intensive Services


Mobile Crisis


Peer-based Crisis Services


Urgent Care


23-hour Observation Bed


Medically Monitored Intensive Inpatient for SUD


24/7 Crisis Hotline


Other


Smartphone Apps


Personal Protective Equipment


Virtual/Telehealth/Telemedicine Services


Purchase of increased connectivity (e.g., Wi-Fi)


Cost-sharing Assistance (e.g., copayments, coinsurance and deductibles)


Provider Stabilization Payments


Transportation to COVID-19 Services (e.g., testing, vaccination)


Other (Please List)


*Only designated states as defined in 42 U.S.C. § 300x-24(b)(2) and 45 CFR § 96.128(b) for the applicable federal fiscal year should enter information in this row. This may include a state or states that were previously considered “designated states” during any of the thre prior federal fiscal years for which a state was applying for a grant. See EIs/HIV policy change in SABG Annual Report instructions.




Table 2B

Service

Expenditures

Healthcare Home/Physical Health

$

Specialized Outpatient Medical Services


Acute Primary Care


COVID-19 Screening (e.g., temperature checks, symptom questionnaires)


COVID-19 Testing


COVID-19 Vaccination


Comprehensive Care Management


Care Coordination and Health Promotion


Comprehensive Transitional Care


Individual and Family Support


Referral to Community Services Dissemination


Prevention (Including Promotion)


Screening with Evidence-based Tools


Risk Messaging


Access Line/Crisis Phone Line/Warm Line


Purchase of Technical Assistance


COVID-19 Awareness and Education for Person with SUD


Media Campaigns (Information Dissemination)


Primary Substance Use Disorder Prevention (Education)


Primary Substance Use Disorder Prevention (Alternatives)


Employee Assistance Programs (Problem Identification and Referral)


Primary Substance Use Disorder Prevention (Community-Based Processes)


Primary Substance Use Disorder Prevention (Environmental)


Intervention Services


Fentanyl Strips


Syringe Services Program


Naloxone


Overdose Kits/Dissemination of Overdose Kits


Engagement Services


Assessment


Specialized Evaluations (Psychological and Neurological)


Services Planning (including crisis planning)


Consumer/Family Education


Outreach (including hiring of outreach workers)


Outpatient Services


Evidence-based Therapies


Group Therapy


Family Therapy


Multi-family Therapy


Consultation to Caregivers


Medication Services


Medication Management


Pharmacotherapy (including MAT)


Laboratory Services


Community Support (Rehabilitative)


Parent/Caregiver Support


Case Management


Behavior Management


Supported Employment


Permanent Supported Housing


Recovery Housing


Recovery Supports


Peer Support


Recovery Support Coaching


Recovery Support Center Services


Supports for Self-Directed Care


Supports (Habilitative)


Personal Care


Respite


Supported Education


Acute Intensive Services


Mobile Crisis


Peer-based Crisis Services


Urgent Care


23-hour Observation Bed


Medically Monitored Intensive Inpatient for SUD


24/7 Crisis Hotline


Other


Smartphone Apps


Personal Protective Equipment


Virtual/Telehealth/Telemedicine Services


Purchase of increased connectivity (e.g., Wi-Fi)


Cost-sharing Assistance (e.g., copayments, coinsurance and deductibles)


Provider Stabilization Payments


Transportation to COVID-19 Services (e.g., testing, vaccination)


Other (Please List)














































SABG Table 3 Syringe Services Program


Table 3 provides a report of SABG, COVID-19, and state expenditures by the SSA during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds for authorized activities to prevent and treat SUDs. For detailed instructions, refer to those in the Block Grant Application System (BGAS).


Shape3


Table 3A Syringe Services Program

Report period

From:

To:

State Identifier:

Syringe Services Program (SSP) Agency Name

Main Address of SSP

Dollar amount of SABG funds used for SSP

Dollar amount of COVID-19 Relief Supplemental Funds Expended for SSP0

SUD Treatment Provider

(Yes or No)

# of locations (include any mobile locations)

Narcan® Provider

(Yes or No)

Fentanyl Strips

(Yes or No)





Yes

No


Yes

No

Yes

No
















































Table 3B SABG - Syringe Services Program

This table is intended to capture the unduplicated count of persons that received onsite services from an SSP or were referred to services by an SSP including HIV, Hepatitis C, and sexually transmitted disease testing, treatment for substance use conditions, and treatment for physical health.


SABG

Syringe Services Program Name

# of Unique Individuals Served

HIV

Testing (Please enter total number of individuals served)

Treatment for Substance Use Conditions (Please enter total number of individuals served)

Treatment for Physical Health (Please enter total number of individuals served)

STD

Testing (Please enter total number of individuals served)

Hep C

(Please enter total number of individuals served)

ONSITE

testing

REFERRAL to

testing

ONSITE

treatment

REFERRAL to

treatment

ONSITE

treatment

REFERRAL to

treatment

ONSITE

testing

REFERRAL to

testing

ONSITE

testing

REFERRAL to

testing













COVID-190

Syringe Services Program Name

# of Unique Individuals Served

HIV

Testing (Please enter total number of individuals served)

Treatment for Substance Use Conditions (Please enter total number of individuals served)

Treatment for Physical Health (Please enter total number of individuals served)

STD

Testing (Please enter total number of individuals served)

Hep C

(Please enter total number of individuals served)



ONSITE

testing

REFERRAL to

testing

ONSITE

treatment

REFERRAL to

treatment

ONSITE

treatment

REFERRAL to

treatment

ONSITE

testing

REFERRAL to

testing

ONSITE

testing

REFERRAL to

testing












SABG Table 4 - State Agency SABG Expenditure Compliance Report


This table provides a description of SABG expenditures for authorized activities to prevent and treat SUDs. For detailed instructions, refer to those in BGAS. Only one column is to be filled in each year.



State Agency SABG Expenditure Compliance Report

SABG Table 4

FY 2016 SA Block Grant Award

FY 2017 SA Block Grant Award

State Identifier:


Expenditure Category






1. Substance Abuse Prevention* and Treatment




2. Primary Prevention




3. Early Intervention Services Regarding the Human Immunodeficiency Virus (EIS/HIV)**




4. Tuberculosis Services




5. Administration (excluding program / provider level)



6. Total



* Prevention other than Primary Prevention

** Only designated states as defined in 42 U.S.C. § 300x-24(b)(2) and 45 CFR § 96.128(b) for the applicable federal fiscal year should enter information in this row. This may include a state or states that were previously considered “designated states” during any of the thre prior federal fiscal years for which a state was applying for a grant. See EIs/HIV policy change in SABG Annual Report instructions

SABG Table 5a - Primary Prevention Expenditures Checklist


The State or jurisdiction must complete either SABG Table 5a and/or 5b. There are six primary prevention strategies typically funded by principal agencies administering the SABG. Expenditures within each of the six strategies or Institute of Medicine Model (IOM) should be directly associated with the cost of completing the activity or task. For example, information dissemination may include the cost of developing pamphlets, the time of participating staff and/or the cost of public service announcements, etc. If a state or jurisdiction employs strategies not covered by these six categories, please report them under “Other,” each in a separate row.


Section 1926 – Tobacco: Costs associated with the Synar Program Pursuant to the January 19, 1996 federal regulation “Tobacco Regulation for Substance Abuse Prevention and Treatment Block Grants, Final Rule” (45 CFR § 96.130), a state may not use the SABG to fund the enforcement of its statute, except that it may expend funds from its primary prevention set aside of its Block Grant allotment under 45 CFR § 96.124(b)(1) for carrying out the administrative aspects of the requirements, such as the development of the sample design and the conducting of the inspections.

States should include any non-SABG funds* that were allotted for Synar activities in the appropriate columns under 7 below.


Plan Table 5a: SABG Primary Prevention Planned Expenditures

Planning Period Start Date: 10/1/2019 Planning Period Start Date: 9/30/2021


A

B

C

D

E

Strategy


IOM Target

FFY 2020 SA Block Grant Award

FFY 2021 SA Block Grant Award

COVID-191

ARP2

1. Information Dissemination

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





2. Education

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





3. Alternatives

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$

4. Problem Identification and Referral to Education

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





5. Community-Based Processes

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





6. Environmental

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





7. Section 1926-Tobacco

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total





8. Other

Universal

$

$

$

$


Selected

$

$

$

$


Indicated

$

$

$

$


Unspecified

$

$

$

$


Total

$

$

$

$

Total Prevention Expenditures






Total SABG Award*


$

$

$

$

Planned Primary Prevention Percentage


%

%

%

%




*Total SABG Award is populated from Table 4 - SABG Planned Expenditures

1The 24-month expenditure period for the COVID-19 Relief Supplemental funding is March 15, 2021 – March 14, 2023. Per the instructions, the planning period for the standard SABG expenditures for the FFY 2021 SABG Award is October 1, 2020 – September 30, 2021. For purposes of this table, all COVID-19 Relief Supplemental expenditures between March 15, 2021 and September 30, 2021 should be entered in this column.

2The expenditure period for The American Rescue Plan Act of 2021 (ARP) supplemental funding is September 1, 2021 - September 30, 2025, which is different from the expenditure period for the FY 2021 "standard" SABG, which is October 1, 2020 - September 30, 2021. The planned expenditures for the period of September 1, 2021 - September 30, 2021 should be entered here.


SABG Table 5b - SABG Primary Prevention Expenditures by Institute of Medicine (IOM) Categories


The state or jurisdiction must complete SABG Table 5b if it chooses to report SUD primary prevention activities utilizing the IOM Model of Universal, Selective and Indicated. Indicate how much funding supported each of the IOM classifications of Universal, Selective, or Indicated. Include all funding sources (e.g., Centers for Disease Control and Prevention Block Grant, foundations). For detailed instructions, refer to those in the Block Grant Application System (BGAS).



Plan Table 5b: SABG Primary Prevention Planned Expenditures by IOM Category


Planning Period Start Date: 10/1/2019 Planning Period Start Date: 9/30/2021

Activity

FFY 2020 SA Block Grant Award

FFY 2021 SA Block Grant Award

COVID-19 Award1

ARP Award2

Universal Direct

$

$

$

$

Universal Indirect

$

$

$

$

Selective

$

$

$

$

Indicated

$

$

$

$

Column Total

$

$

$

$

Total SABG Award3

$

$

$

$

Planned Primary Prevention

Percentage

%

%

%

%

1The 24-month expenditure period for the COVID-19 Relief Supplemental funding is March 15, 2021 - March 14, 2023. Per the instructions, the planning period for the standard SABG expenditures for the FFY 2021 SABG Award is October 1, 2020 - September 30, 2021. For purposes of this table, all COVID-19 Relief Supplemental expenditures between March 15, 2021 and September 30, 2021 should be entered in this column.

2The expenditure period for The American Rescue Plan Act of 2021 (ARP) supplemental funding is September 1, 2021 - September 30, 2025, which is different from the expenditure period for the FY 2021 "standard" SABG, which is October 1, 2020 - September 30, 2021. The planned expenditures for the period of September 1, 2021 - September 30, 2021 should be entered here.

3Total SABG Award is populated from Table 4 - SABG Planned Expenditures




SABG Table 5c (Requested) - SABG Primary Prevention Targeted Priorities


The purpose of the first table is for the state or jurisdiction to identify the substance and/or categories of substances it identified through its needs assessment and then addressed with primary prevention set-aside dollars from the FY 2016 SABG NoA. The purpose of the second table is to identify each special population the state or jurisdiction selected as a priority for primary prevention set-aside expenditures.




SABG Award

COVID-19 Award1

ARP Award2

Targeted Substances


Alcohol




Tobacco




Marijuana




Prescription Drugs




Cocaine




Heroin




Inhalants




Methamphetamine




Synthetic Drugs (e.g., Bath salts, Spice, K2)





Instructions: In the table below, identify the special population categories the state BG plans to target with primary prevention set-aside dollars.


Targeted Populations

Students in College




Military Families




LGBTQ




American Indians/Alaska Natives




African American




Hispanic




Homeless




Native Hawaiian/Other Pacific Islanders




Asian




Rural




Underserved Racial and Ethnic Minorities




1The 24-month expenditure period for the COVID-19 Relief Supplemental funding is March 15, 2021 – March 14, 2023. Per the instructions, the planning period for the standard SABG expenditures for the FFY 2021 SABG Award is October 1, 2020 – September 30, 2021. For purposes of this table, all COVID-19 Relief Supplemental expenditures between March 15, 2021 and September 30, 2021 should be entered in this column.

2The expenditure period for The American Rescue Plan Act of 2021 (ARP) supplemental funding is September 1, 2021 - September 30, 2025, which is different from the expenditure period for the FY 2021 "standard" SABG, which is October 1, 2020 - September 30, 2021. The planned expenditures for the period of September 1, 2021 - September 30, 2021 should be entered here.


Plan Table #6

Proposed Categories for Expenditures for System Development/Non-Direct-Service Activities

Expenditures in the following categories of activities may involve the time of State or sub-State personnel, or may be funded through contracts, grants, or agreements with other entities. Expenditures may come from the administrative funds and/or program funds (but may not include the HIV set-aside funds). Please utilize the following categories to describe the types of expenditures your state supports with BG funds, and if the preponderance of the activity fits within a category.

We understand that a particular activity may cross categories, but try to identify the primary purpose or goal of the activity. For example, a state may utilize BG funds to train personnel to conduct fidelity assessments of evidence-based practices. While this could fall under either training/education and/or quality assurance/improvement – the primary purpose is to assure the implementation of EBPs, so that expenditure would most likely be captured under quality assurance/improvement.

Information systems This includes collecting and analyzing treatment data as well as prevention data under the SABG in order to monitor performance and outcomes. Costs for electronic health records and other health information technology also fall under this category.


Infrastructure Support – This includes activities that provide the infrastructure to support services but for which there are no individual services delivered. Examples include the development and maintenance of a crisis-response capacity, including hotlines, mobile crisis teams, web-based check-in groups (for medication, treatment, re-entry follow-up), drop-in centers, and respite services.


Partnerships, community outreach, and needs assessment This includes state, regional, and local personnel salaries prorated for time and materials to support planning meetings, information collection, analysis, and travel. It also includes the support for partnerships across state and local agencies, and tribal governments. Community/network development activities, such as marketing, communication, and public education, and including the planning and coordination of services, fall into this category, as do needs-assessment projects to identify the scope and magnitude of the problem, resources available, gaps in services, and strategies to close those gaps.


Planning Council Activities – This includes those supports for the performance of a Mental Health Planning Council under the MHBG, a combined Behavioral Health Planning Council, or (OPTIONAL) Advisory Council for the SABG.


Quality assurance and improvement – This includes activities to improve the overall quality of services, including those activities to assure conformity to acceptable professional standards, adaptation and review of implementation of evidence-based practices, identification of areas of technical assistance related to quality outcomes, including feedback. Administrative agency contracts to monitor service-provider quality fall into this category, as do independent peer-review activities.


Research and evaluation – This includes performance measurement, evaluation, and research, such as services research and demonstration projects to test feasibility and effectiveness of a new approach as well as the dissemination of such information.

Training and education– This includes skill development and continuing education for personnel employed in local programs as well as partnering agencies, as long as the training relates to either substance use disorder service delivery (prevention, treatment and recovery) for SABG and services to adults with SMI or children with SED for MHBG. Typical costs include course fees, tuition, and expense reimbursements to employees, trainer(s) and support staff salaries, and certification expenditures.





Non-Direct-Services/System Development


SABG/MHBG Table 6


State Identifier:


Report Period- From: To:

Activity

A. MHBG

B. SABG Treatment

C. SABG Prevention

D. SABG Integrated 0

1. Information Systems

$

$

$

$

2. Infrastructure Support

$

$

$

$

3. Partnerships, community outreach, and needs assessment

$

$

$

$

4. Planning Council Activities (MHBG required, SABG optional)

$

$

$

$

5. Quality assurance and improvement

$

$

$

$

6. Research and Evaluation

$

$

$

$

7. Training and Education

$

$

$

$

8. Total

$

$

$

$


Please enter the total amount of the block grant expended for each activity.



*Combined refers to funds both treatment and prevention portions of the SABG for overarching activities.





SABG Table 7 State Entity Inventory


This table provides a report of the sub-recipients of SABG funds including community- and faith-based organizations which provided SUD prevention activities and treatment services, as well as intermediaries/administrative service organizations. Table 7 excludes system development/non-direct service expenditures. For detailed instructions, see those in BGAS.


Statewide Entity Inventory

SABG Table 7

State Identifier:

Report Period- From: To:


Source of Funds


SAPT Block Grant

A

B

B

D

E

F

Entity Number

I-BHS ID

(formerly I-SATS)

Area Served (Statewide or Sub- State

Planning Area)

Provider/Program Name

Street Address

City

State

Zip

All SA Block Grant Funds

Prevention (other than Primary Prevention) and

Treatment Services

Pregnant Women and Women with

Dependent Children

Primary Prevention

Early Intervention Services for HIV

Syringe Services Program









$

$

$

$

$

$









$

$

$

$

$

$

Total








$

$

$

$

$

$










Description of Calculations for MOE Tables 8a and 8b


Please provide a description of the amounts and methods used to calculate the following:

    1. total Single State Agency (SSA) expenditures for SUD prevention and treatment as required by: a. 42 U.S.C. § 300x-30 and 45 CFR § 96.124(f)(4)

    2. the base and, for 1994 and subsequent fiscal years, report the federal and state expenditures for services to pregnant women and women with dependent children as required by:

a. 42 U.S.C. § 300x-22(b)(1) and 45 CFR § 96.122(f)(5)(ii)(A)



SABG Table 8a - Maintenance of Effort for State Expenditures for SUD Prevention and Treatment


This Maintenance of Effort table provides a description of non-federal expenditures for authorized activities to prevent and treat substance abuse flowing through the Single State Agency (SSA) during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. (Dates given are for the FY 2017 SABG Report. For the FY 2018 SABG report, increase each year by one.)


For detailed instructions, see those in BGAS.



SABG Table 8a Total Single State Agency (SSA) Expenditures for Substance Abuse Prevention and Treatment

State Identifier:

Report Period- From: To:


Period



(A)


Expenditures



(B)


B1 (2014) + B2 (2015)

2


(C)

SFY 2017

(1)



SFY 2018

(2)



SFY 2019

(3)



Are the expenditure amounts reported in Column B “actual” expenditures for the fiscal years involved?


Yes

No

SFY 2017



SFY 2018



SFY 2019





If any estimated expenditures are provided, please indicate when “actual” expenditure data will be submitted to SAMHSA:

mm

Did the state or jurisdiction have any non-recurring expenditures as described in 42 U.S.C. § 300x-30(b) for a specific purpose which were not included in the MOE calculation? Yes No

If yes, specify the amount and the State fiscal year

Did the state or jurisdiction include these funds in previous year MOE calculations? Yes No

When did the State or Jurisdiction submit an official request to SAMHSA to exclude these funds from the MOE calculations?


SABG Table 8b - Expenditures for Services to Pregnant Women and Women with Dependent Children


This table provides a report of all statewide, non-federal funds expended on specialized treatment and related services which meet the SABG requirements for pregnant women and women with dependent children during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. (Dates given are for the FY 2017 SABG Report. For the FY 2018 SABG Report, increase each year (other than the base year) by one.)


For detailed instructions, see those in BGAS.




Expenditures for Services to Pregnant Women and Women with Dependent Children

SABG Table 8b

State Identifier:

Report Period- From: To:

eriod

Total Women’s Base (A)

Total Expenditures (B)

1994



2017



2018



2019






  1. Populations and Services Report


States are required to provide information regarding individuals that are served by the SSA in SABG Tables 9 through 13.


SABG Table 9 - Prevention Strategy Report This table requires additional information (pursuant to Section 1929 of Title XIX, Part B, Subpart II of the PHS Act (42 U.S.C. § 300x-29) about the primary prevention activities conducted by the entities listed on SABG Table 7, State Entity Inventory, Column D. It seeks further information on the specific strategies and activities being funded by the principal agency of the state which address the sub-populations at risk for alcohol, tobacco, and other drug (ATOD) use/abuse.

SABG Table 10 - Treatment Utilization Matrix This table is intended to capture the count of persons with initial admissions and subsequent admission(s) to an episode of care (as defined in the Behavioral Health Services Information System (BHSIS), formerly known as the Drug and Alcohol Services Information System (DASIS), Treatment Episode Data Set (TEDS) standards (see TEDS data) during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds.

SABG Table 11a - Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use. This table provides an aggregate profile of the unduplicated number of admissions and persons for services funded through the SABG during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. States are to provide this information on all programs by age, gender, and race/ethnicity. States are to report whether the values reported come from a client-based system(s) with unique client identifiers.

SABG Table 11b – COVID-19 Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use. This table provides an aggregate profile of the unduplicated number of admissions and persons for services funded with COVID-19 Relief Supplement funds during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. States are to provide this information on all programs by age, gender, and race/ethnicity. States are to report whether the values reported come from a client- based system(s) with unique client identifiers.

SABG Table 11c – Sex, Sexual Orientation, and Gender Identity Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use. This table provides an aggregate profile of the unduplicated number of admissions and persons for services funded through the SABG during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds by sex, sexual orientation, and gender identity. States are to report whether the values reported come from a client- based system(s) with unique client identifiers.

SABG Table 12 – SABG Designated States and Early Intervention Services Regarding the Human Immunodeficiency Virus. This table requires designated states as defined in section 1924(b)(2) of Title XIX, Part B, Subpart II of the PHS Act (42 U.S.C. § 300x-24(b)(2)), to provide information on Early Intervention Services Regarding the Human Immunodeficiency Virus (EIS/HIV) provided during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds.

SABG Table 13 - Charitable Choice This table requires states to provide information regarding compliance with section 1955 of Title XIX, Part B, Subpart III of the PHS Act (42 U.S.C. § 300x-65) and the Charitable Choice Provisions and Regulations; Final Rule (42 CFR Part 54) during the state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds.

Each section of this table requires that the state respond appropriately to identify the manner in which they have complied with the requirements related to authorizing legislation and implementing regulation. States should report on the number of clients referred, due to religious objection, from faith and community-based programs to appropriate alternative providers. If no alternate referrals were made, enter zero.


SABG Table 9 - Prevention Strategy Report


This table requires additional information (pursuant to Section 1929 of Title XIX, Part B, Subpart II of the PHS Act (42 U.S.C.§ 300x- 29) about the primary prevention activities conducted by the entities listed on SABG Table 7. For detailed instructions, see those in BGAS.Prevention Strategy Report Risk-Strategies

SABG Table 9

Report Period- From: To:

State Identifier

Column A (Risks)

Column B (Strategies)

Column C (Providers)



Children of Substance Abusers [1]




Pregnant Women / Teens [2]




Drop-Outs [3]




Violent and Delinquent Behavior [4]




Mental Health Problems [5]




Economically Disadvantaged [6]




Physically Disabled [7]




Abuse Victims [8]




Already Using Substances [9]




Homeless and/or Runaway Youth [10]




Other, Specify [11]






SABG Table 10 Treatment Utilization Matrix

This table is intended to capture the count of persons with initial admissions and subsequent admission(s) to an episode of care. For detailed instructions, see those in BGAS.

For detailed instructions, see those in BGAS.


Expenditure Period Start Date: 7/1/2020 Expenditure Period End Date: 6/30/2021


Level of Care

SABG Number of Admissions ≥

Number of Persons Served

COVID-19 Number of Admissions ≥

Number of Persons Served0

SABG Costs per Person

(C, D & E)

COVID-19 Costs per Person

(C, D & E)1

Number of Admissions

(A)

Number of Persons Served

(B)

Number of Admissions

(A)

Number of Persons Served

(B)

Mean Cost of

Services

(C)

Median Cost of Services

(D)

Standard Deviation of Cost

(E)

Mean Cost of Services

(C)

Median Cost of Services

(D)

Standard Deviation of Cost

(E)

DETOXIFICATION (24-HOUR CARE)

1. Hospital Inpatient

1778

939

1411

877







2. Free-Standing Residential











REHABILITATION/RESIDENTIAL

3. Hospital Inpatient

0

2789

4066

0

2724

4066







4. Short-term (up to 30 days)











5. Long-term (over 30 days)











AMBULATORY (OUTPATIENT)

6. Outpatient

13591

3426

0

13591

3282

0

$0



$0



7. Intensive Outpatient











8. Detoxification










$0

OUD MEDICATION ASSISTED TREATMENT

9. OUD Medication-Assisted Detoxification0

0


14728

0


14728

$0



$0


$0

10. OUD Medication-Assisted Treatment Outpatient0













SABG Table 11 - Unduplicated Count of Persons Served for Alcohol and Other Drug Use


This table provides an aggregate profile of the unduplicated number of admissions and persons for services funded through the SABG. For detailed instructions, see those in BGAS.




SABG Table 11a


Report Period- From: To::

State Identifier:

Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use in State Funded Services by Age, Sex and Race/Ethnicity


Sex and Race/Ethnicity

Age

A. Total

B. White

C. Black or African American

D. Native Hawaiian/ Other Pacific Islander

E. Asian

F. American Indian/Alaska n Native

G. More Than One Race Reported

H. Unknown

I. Not Hispanic or Latino

J. Hispanic or Latino

M

F

M

F

M

F

M

F

M

F

M

F

M

F

M

F

M

F

1. 17 and under




















2. 18-24




















3. 25-44




















4. 45-64




















5. 65 and

over




















5. Total




















7. Pregnant

Women




















Numbers of Persons Served who were admitted in a Period Prior to the 12 month

reporting Period



Number of persons served

outside of the levels of care described on SABG Table 10


Are the values reported in this table generated from a

client based system with unique client identifiers?


Yes

No


SABG Table 11b


Report Period- From:

To::

State Identifier:

Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use in State Funded Services by Age, Sex and Race/Ethnicity (COVID-19 Supplemental Award


Sex and Race/Ethnicity

Age

A. Total

B. White

C. Black or African American

D. Native Hawaiian/ Other Pacific Islander

E. Asian

F. American Indian/Alaska n Native

G. More Than One Race Reported

H. Unknown

I. Not Hispanic or Latino

J. Hispanic or Latino

M

F

M

F

M

F

M

F

M

F

M

F

M

F

M

F

M

F

1. 17 and under




















2. 18-24




















3. 25-44




















4. 45-64




















5. 65 and

over




















5. Total




















7. Pregnant

Women




















Numbers of Persons Served who were admitted in a Period Prior to the 12 month

reporting Period



Number of persons served

outside of the levels of care described on SABG Table 10


Are the values reported in this table generated from a

client based system with unique client identifiers?


Yes

No



SABG Table 11c


Report Period- From: To:

State Identifier:

Number of Persons Served (Unduplicated Count) for Alcohol and Other Drug Use in State Funded Services by Sex, Sexual Orientation, and Gender Identity

AGE

Male

Female

Transgender Man /Transman /Female-To-Man

Transgender Woman/ Transwoman/ Male-To-Female

Genderqueer/ Gender Non-Conforming/ Neither Exclusively Male or Female

  Additional Gender Category (or Other)

Straight or Heterosexual

Gay or Lesbian

Bisexual

Queer, Pansexual, and/or Questioning

Something Else? Please Specify

17 and Under

 

 

 

 

 

 






 

 

 

 

 

 

 






18-24

 

 

 

 

 

 






 

 

 

 

 

 

 






25-44

 

 

 

 

 

 






 

 

 

 

 

 

 






45-64

 

 

 

 

 

 






 

 

 

 

 

 

 






65 and over

 

 

 

 

 

 






 

 

 

 

 

 

 






TOTAL

 

 

 

 

 

 






 

 

 

 

 

 

 









SABG Table 12 - SABG Early Intervention Services Regarding the Human Immunodeficiency Virus (EIS/HIV) in Designated States


For detailed instructions, see those in BGAS.


SABG Table 12


Report Period- From: To::

State Identifier

Early Intervention Services Regarding the Human Immunodeficiency Virus (EIS/HIV)

1. Number of EIS/HIV projects among SABG sub-recipients in the

state:

Statewide:

Rural:

2. Total number of individuals tested through SABG sub-recipient EIS/HIV projects:



3. Total number of HIV tests conducted with SABG EIS/HIV funds:



4. Total number of tests that were positive for HIV:



5. Total number of individuals who prior to the 12-month reporting period were unaware of their HIV infection:



6. Total number of HIV-infected individuals who were diagnosed and referred into treatment and care during the 12-month reporting period



Identify barriers, including state laws and regulations, that exist in carrying out HIV testing services:

SABG Table 13 - Charitable Choice – Required


Under Charitable Choice Provisions; Final Rule (42 CFR Part 54), states, local governments, and religious organizations, such as SAMHSA grant recipients, must: (1) ensure that religious organizations that are providers provide to all potential and actual program beneficiaries (services recipients) notice of their right to alternative services; (2) ensure that religious organizations that are providers refer program beneficiaries to alternative services; and (3) fund and/or provide alternative services. The term “alternative services” means services determined by the state to be accessible and comparable and provided within a reasonable period of time from another substance abuse provider (“alternative provider”) to which the program beneficiary (services recipient) has no religious objection. The purpose of this table is to document how the state is complying with these provisions.


Notice to Program Beneficiaries Check all that apply:


  • Used model notice provided in final regulations.


  • Used notice developed by state (please attach a copy to the Report)


  • State has disseminated notice to religious organizations that are providers.


  • State requires these religious organizations to give notice to all potential beneficiaries.


Referrals to Alternative Services Check all that apply:


  • State has developed specific referral system for this requirement.


  • State has incorporated this requirement into existing referral system(s).


  • SAMHSA’s Behavioral Health Treatment Locator is used to help identify providers.


  • Other networks and information systems are used to help identify providers.


  • State maintains record of referrals made by religious organizations that are providers.


Enter the total number of referrals to other substance abuse providers (“alternative providers”) necessitated by religious objection, as defined above, made during the State fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. Provide the total only. No information on specific referrals is required. If no alternative referrals were made, enter zero.


Provide a brief description (one paragraph) of any training for local governments and/or faith-based and/or community organizations that are providers on these requirements.


  1. Performance Data and Outcomes


SAMHSA is interested in demonstrating program accountability and efficacy through the National Outcome Measures (NOMs). The NOMs are intended to document the performance of federally supported programs and systems of care.

Treatment Performance Measures


SABG Table 14 Employment/Education Status This table describes the status of adult clients served by the public SUD treatment service systems in terms of employment and education status. The Employment\Education Status Form seeks information on clients who are employed or who are students (full-time or part-time) (prior 30 days) at admission and discharge.

SABG Table 15 Stability of Housing This table requests information regarding the number of individuals in a stable living environment as collected by the most recent assessment in the reporting period. Specifically, information is collected on the individual’s last known living situation.

SABG Table 16 Criminal Justice Involvement This table requests information regarding the clients’ involvement in the criminal justice system. Specifically, the table requests information to measure the change in number of arrests over time.

SABG Table 17 Change in Abstinence - Alcohol Use This table seeks information regarding alcohol abstinence. Specifically, information is collected on the number of clients with no alcohol use (all clients regardless of primary problem) at admission and discharge.

SABG Table 18 Change in Abstinence - Other Drug Use This table collects information regarding clients’ change in abstinence with drugs of abuse other than alcohol. This table seeks to collect information on clients with no other drug use (all clients regardless of primary problem) at admission and discharge.

SABG Table 19 Change in Social Support of Recovery This table seeks to measure the change in clients’ social support of recovery. Specifically, this form collects information regarding the number of clients participating in self-help groups at admission and discharge.

SABG Table 20 Retention This table collects information regarding retention. Specifically, this table collects information regarding the length of stay of clients completing treatment.

Prevention Performance Measures

SABG Table 20 Reduced Morbidity –Abstinence from Drug Use/Alcohol Use; Measure: 30 Day Use. This table seeks information regarding 30 day use of alcohol, tobacco and other drugs.

SABG Table 22 Reduced Morbidity –Abstinence from Drug Use/Alcohol Use; Measure: Perception of Risk/Harm of Use. This table seeks information regarding the individuals’ perceived risk of harming themselves with alcohol, tobacco and other drugs.

SABG Table 23 Reduced Morbidity–Abstinence from Drug Use/Alcohol Use; Measure: Age of First Use. This table seeks information regarding the age of first use of alcohol, cigarettes and other drugs.

SABG Table 24 Reduced Morbidity–Abstinence from Drug Use/Alcohol Use; Measure: Perception of Disapproval/Attitudes. This table seeks information regarding the general public perception or attitude regarding use of alcohol, cigarettes and other drugs.

SABG Table 25 Employment/Education; Measure: Perception of Workplace Policy. This table reports the percent of individuals who would be more likely to work for an employer conducting random drug and alcohol tests.

SABG Table 26 Employment/Education; Measure: Average Daily School Attendance Rate. This table collects information regarding the average daily school attendance.

SABG Table 27 Crime and Criminal Justice; Measure: Alcohol-Related Traffic Fatalities. This table collects information regarding the number of alcohol-related traffic fatalities divided by the total number of traffic fatalities and multiplied by 100.

SABG Table 28 Crime and Criminal Justice; Measure: Alcohol and Drug Related Arrests. This table collects information regarding alcohol- and drug-related arrests.

SABG Table 29 Social Connectedness; Measure: Family Communications around Drug and Alcohol Use. This table provides information regarding the percent of youth reporting having talked with a parent and the percent of parents reporting that they have talked to their child around alcohol and drug use.

SABG Table 30 Retention; Measure: Percentage of Youth Seeing, Reading, Watching, or Listening to a Prevention Message. This table collects information regarding the percent of youth reporting having been exposed to prevention message.

SABG Table 31 Individual-Based Programs and Strategies; Measure: Number of Persons Served By Age, Gender, Race, and Ethnicity. This table provides information on the number of persons served by individual-based programs and strategies. This includes practices and strategies with identifiable goals designed to change behavioral outcomes among a definable population or within a definable geographic area.

SABG Table 32 Population-Based Programs and Strategies; Measure: Number of Persons Served By Age, Gender, Race, and Ethnicity. This table provides information regarding the number of persons by age, gender, race, and ethnicity that participated in population-based programs.

Population-based programs and strategies include planned and deliberate goal-oriented practices, procedures, processes, or activities that have identifiable outcomes achieved with a sequence of steps subject to monitoring and modification.

SABG Table 33 Number of Persons Served by Type of Intervention. This table seeks to measure information on access and capacity of intervention programs. Specifically, this form collects information on the number of persons served by type of Intervention. Interventions include activities, practices, procedures, processes, programs, services, and strategies.


SABG Table 34 Number of Evidence-Based Programs by Types of Intervention. This table collects information on the number of evidence-based programs and strategies by type of intervention.

SABG Table 35 Number of Evidence-based Programs and Strategies, and Total SABG Funds Spent on Evidence-Based Programs/ Strategies.



36

SABG Table 14 TREATMENT PERFORMANCE MEASURE

Shape4

Employment\Education Status Clients employed or student (full-time or part-time) (prior 30 days) at admission vs. discharge

Admission Clients (T1)

Discharge Clients (T2)

Number of clients employed or student (full-time and part-time) [numerator]



Total number of clients with non-missing values on employment\student status [denominator]



Percent of clients employed or student (full-time and part-time)




EMPLOYMENT\EDUCATION STATUS (From Admission to Discharge) Most recent year for which data are available:







































State Description of Employment\Education Status Data Collection (SABG Table 15)


STATE CONFORMANCE TO INTERIM STANDARD

State Description of Employment\Education Data Collection (SABG Table 15):

States should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 15 (select all that apply):

Client self-report Client self-report confirmed by another source→ collateral source

Administrative data source Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 15 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge

is on the last date of service in a Program/Service Delivery Unit

  • Other Specify _

DISCHARGE DATA COLLECTION

How was discharge data collected for SABG Table 15 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→

Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post- admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted

for treatment

RECORD LINKING

Was the admission and discharge data linked for table 15 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client

Identifier (UCID)

Select type of UCID □ Master Client Index or Master Patient Index, centrally assigned □ Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) □ Some other Statewide unique ID □ Provider- entity-specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State relied on other data sources for post admission data □ No, admission and discharge

records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE

If data is not reported, why is State unable to report (select all that apply):

Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested State collects information on the

indicator area but utilizes a different measure.

DATA PLANS IF DATA IS NOT AVAILABLE

State must provide time-framed plans for capturing employment\student status data on all clients, if data is not currently available. Plans should also discuss barriers, resource needs and estimates of cost.

SABG Table 15–TREATMENT PERFORMANCE MEASURE

STABILITY OF HOUSING (From Admission to Discharge)


Most recent year for which data are available:



Clients living in a stable living situation (prior 30 days) at admission vs. discharge

Admission Clients (T1)

Discharge Clients (T2)

Number of clients living in a stable situation [numerator]



Total number of clients with non-missing values on living arrangements [denominator]



Percent of clients in a stable living situation



State Description of Stability in Housing Data Collection (SABG Table 14)



STATE CONFORMANCE TO INTERIM STANDARD

State Description of Stability in Housing Data Collection (SABG Table 15):

States should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 15 (select all that apply):

Client self-report □ Client self-report confirmed by another source→ □ collateral source Administrative data source Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 15 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge is

on the last date of service in a Program/Service Delivery Unit

  • Other Specify _


DISCHARGE DATA COLLECTION


How was discharge data collected for SABG Table 15 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→

Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post-

  • admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted

for treatment

RECORD LINKING

Was the admission and discharge data linked for SABG Table 15 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client

Identifier (UCID)

Select type of UCID Master Client Index or Master Patient Index, centrally assigned Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) □ Some other Statewide unique ID □ Provider-entity- specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State relied on other data sources for post admission data □ No, admission and discharge records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE



If data is not reported, why is the state unable to report (select all that apply): □ Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested State collects information on the indicator area but

utilizes a different measure.

DATA PLANS IF DATA IS NOT AVAILABLE

State must provide time-framed plans for capturing criminal justice involvement status data on

all clients, if data is not currently available. Plans should also discuss barriers, resource needs and estimates of cost.



SABG Table 16– TREATMENT PERFORMANCE MEASURE

Shape7

Clients without arrests (any charge) (prior 30 days) at admission vs. discharge

Admission Clients

(T1)

Discharge Clients

(T2)

Number of Clients without arrests [numerator]



Total number of clients with non-missing values on arrests [denominator]



Percent of clients without arrests




CRIMINAL JUSTICE INVOLVEMENT (From Admission to Discharge) Most recent year for which data are available:

State Description of Criminal Involvement Data Collection (SABG Table 16)


STATE CONFORMANCE TO INTERIM STANDARD

State Description of Criminal Involvement Data Collection (SABG Table 16):

States should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 16 (select all that apply):

Client self-report □ Client self-report confirmed by another source→ □ collateral source Administrative data source Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 16 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge is on the last date of service in a Program/Service Delivery Unit

  • Other Specify _


DISCHARGE DATA COLLECTION


How was discharge data collected for SABG Table 16 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→

Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post-

  • admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted for treatment

RECORD LINKING

Was the admission and discharge data linked for SABG Table 16 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client Identifier (UCID)

Select type of UCID Master Client Index or Master Patient Index, centrally assigned Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) □ Some other Statewide unique ID □ Provider-entity- specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State relied on other data sources for post admission data □ No, admission and discharge records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE



If data is not reported, why is State unable to report (select all that apply): □ Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested State collects information on the indicator area but

utilizes a different measure.

DATA PLANS IF DATA IS NOT AVAILABLE

State must provide time-framed plans for capturing criminal justice involvement status data on all clients, if data is not currently available. Plans should also discuss barriers, resource needs

and estimates of cost.


42

SABG Table 17– PERFORMANCE MEASURE

Shape9

Alcohol Abstinence – Clients with no alcohol use (all clients regardless of primary problem) (use Alcohol Use in last 30 days field) at admission vs. discharge.


Admission Clients

(T1)


Discharge Clients

(T2)

Number of clients abstinent from alcohol [numerator]



Total number of clients with non-missing values on “used any alcohol” variable [denominator]



Percent of clients abstinent from alcohol



(1) If State does not have a "used any alcohol" variable, calculate instead using frequency of use

variables for all primary, secondary, or tertiary problem codes in which the coded problem is Alcohol (e.g. ,TEDS Code 01)


CHANGE IN ABSTINENCE – ALCOHOL USE (From Admission to Discharge) Most recent year for which data are available:

State Description of Alcohol Use Data Collection (SABG Table 17)


STATE CONFORMANCE TO INTERIM STANDARD

State Description of Alcohol Use Data Collection (SABG Table 17):

State should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 17 (select all that apply):

  • Client self-report □ Client self-report confirmed by another source→ □ urinalysis, blood test or other biological assay collateral source

  • Administrative data source Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 17 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge is

on the last date of service in a Program/Service Delivery Unit

  • Other Specify _

DISCHARGE DATA COLLECTION

How was discharge data collected for SABG Table 17 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→

Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post-

  • admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted for treatment

RECORD LINKING

Was the admission and discharge data linked for SABG Table 17 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client Identifier (UCID)

Select type of UCID Master Client Index or Master Patient Index, centrally assigned Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) □ Some other Statewide unique ID □ Provider-entity- specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State relied on other data sources for post admission data □ No, admission and discharge records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE

If data is not reported, why is State unable to report (select all that apply): □ Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested State collects information on the indicator area but

utilizes a different measure.

DATA PLANS IF DATA IS NOT

AVAILABLE

State must provide time-framed plans for capturing abstinence - alcohol use status data on all clients, if data is not currently available. Plans should also discuss barriers, resource needs and estimates of cost.

SABG Table 18 PERFORMANCE MEASURE

Shape10


Drug Abstinence Clients with no drug use (all clients regardless of primary problem) (use Any Drug Use in last 30 days field) at admission vs. discharge.


Admission Clients

(T1)


Discharge Clients

(T2)

Number of Clients abstinent from illegal drugs [numerator]



Total number of clients with non-missing values on “used any drug” variable [denominator] *



Percent of clients abstinent from drugs




CHANGE IN ABSTINENCE -- OTHER DRUG USE (From Admission to Discharge) Most recent year for which data are available:






*If State does not have a "used any drug" variable, calculate instead using frequency of use variables for all primary, secondary, or tertiary problem codes in which the coded problem is Drugs (e.g., TEDS Codes 01-04)

State Description of Other Drug Use Data Collection (SABG Table 18)


STATE CONFORMANCE TO INTERIM STANDARD

State Description of Other Drug Use Data Collection (SABG Table 18):

States should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 18 (select all that apply):

  • Client self-report Client self-report confirmed by another source→ urinalysis, blood test

or other biological assay collateral source

  • Administrative data source Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 18 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge is

on the last date of service in a Program/Service Delivery Unit

  • Other Specify _

DISCHARGE DATA COLLECTION

How was discharge data collected for SABG Table 18 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→

Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post-

  • admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted

for treatment

RECORD LINKING

Was the admission and discharge data linked for SABG Table 18 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client

Identifier (UCID)

Select type of UCID Master Client Index or Master Patient Index, centrally assigned Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) □ Some other Statewide unique ID □ Provider-entity- specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State relied on other data sources for post admission data □ No, admission and discharge records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE

If data is not reported, why is State unable to report (select all that apply): □ Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested State collects information on the indicator area but

utilizes a different measure.

DATA PLANS IF DATA IS NOT AVAILABLE

State must provide time-framed plans for capturing abstinence drug use status data on all

clients, if data is not currently available. Plans should also discuss barriers, resource needs and estimates of cost.

SABG Table 19 PERFORMANCE MEASURE

CHANGE IN SOCIAL SUPPORT OF RECOVERY (From Admission to Discharge)


Most recent year for which data are available:



Social Support of Recovery – Clients participating in self-help groups (e.g., AA, NA, etc.) (prior 30 days) at admission vs. discharge

Admission Clients

(T1)

Discharge Clients

(T2)

Number of clients participating in self-help (AA NA meetings attended, etc.)

[numerator]



Total number of Admission and Discharge clients with non-missing values on self- help activities [denominator]



Percent of clients participating in self-help activities



State Description of Social Support of Recovery Data Collection (SABG Table 19)


STATE CONFORMANCE TO INTERIM STANDARD

State Description of Social Support of Recovery Data Collection (SABG Table 19):

States should detail exactly how this information is collected. Where data and methods vary from interim standard, variance should be described.

DATA SOURCE

What is the source of data for SABG Table 19 (select all that apply):

  • Client self-report Client self-report confirmed by another source→

  • collateral source Administrative data source

  • Other Specify

EPISODE OF CARE

How is the admission/discharge basis defined for SABG Table 19 (Select one) □ Admission is on the first date of service, prior to which no service has been received for 30 days AND discharge is on the last date of service, subsequent to which no service has been received for 30 days

  • Admission is on the first date of service in a Program/Service Delivery Unit and Discharge is on the last date of service in a Program/Service Delivery Unit

  • Other Specify _

DISCHARGE DATA COLLECTION

How was discharge data collected for SABG Table 19 (select all that apply)

  • Not applicable, data reported on form is collected at time period other than discharge→ Specify:

  • In-treatment data days post-admission, OR Follow-up data (specify) months Post- admission discharge other

  • Discharge data is collected for the census of all (or almost all) clients who were admitted to treatment Discharge data is collected for a sample or all clients who were admitted to treatment □ Discharge records are directly collected (or in the case of early dropouts) are created for all (or almost all) clients who were admitted to treatment

  • Discharge records are not collected for approximately % of clients who were admitted for

treatment

RECORD LINKING

Was the admission and discharge data linked for SABG Table 19 (select all that apply):

  • Yes, all clients at admission were linked with discharge data using an Unique Client Identifier

(UCID)

Select type of UCID □ Master Client Index or Master Patient Index, centrally assigned □ Social Security Number (SSN) □ Unique client ID based on fixed client characteristics (such as date of birth, gender, partial SSN, etc.) Some other Statewide unique ID Provider-entity-specific unique ID

  • No, State Management Information System does not utilize UCID that allows comparison of admission and discharge data on a client specific basis (data developed on a cohorts basis) or State

relied on other data sources for post admission data □ No, admission and discharge records were matched using probabilistic record matching.

IF DATA IS UNAVAILABLE

If data is not reported, why is State unable to report (select all that apply): Information is not collected at admission □ Information is not collected at discharge □ Information is not collected by the categories requested □ State collects information on the indicator area but utilizes a different measure.

DATA PLANS IF DATA IS NOT AVAILABLE

State must provide time-framed plans for capturing self-help participation status data on all clients, if

data is not currently available. Plans should also discuss barriers, resource needs and estimates of cost.

SABG Table 20: RETENTION

Length of Stay (in Days) of Clients Completing Treatment Most recent year for which data are available:

LENGTH OF STAY


Level of Care


Av e r a g e ( Me a n)


Me di an

( Me di an)


Int erqu art ile Ra ng e


Detoxification (24-hour care)

1. Hospital Inpatient




2. Free-Standing Residential





Rehabilitation/Residential

3. Hospital Inpatient




4. Short-term (up to 30 days)




5. Long-term

(over 30 days)





Ambulatory (Outpatient)

6. Outpatient




7. Intensive Outpatient




8. Detoxification





OUD Medication-Assisted Treatment

9. OUD Medication-Assisted Detoxification0




10. OUD Medication-Assisted Treatment Outpatient0



Section V: Performance Indicators and Accomplishments Tables 21-36: Prevention Performance Measures

Tables 21 30 Prevention Performance Measures

Introduction

The National Outcome Measures (NOMs) are a set of domains and measures that the Substance Abuse and Mental Health Services Administration (SAMHSA) uses to accomplish its vision and to meet all of its federal reporting requirements, thus reducing burden and redundancy for grantees.


The NOMs Data Collection and Reporting tables are to be completed as part of the state's annual SABG application. For Tables 21-25 and 27-30, the compliance year is calendar year (CY) 2017 (note that pre-populated NOMs from the National Survey on Drug Use and Health (NSDUH) reflect pooled data from CYs 2016-2017. For substance abuse prevention NOMs Table 26, the compliance year is School Year 2017.


For purposes of this section, unless otherwise noted, the term "state" refers to states, territories, and the one Native American tribe that receive SABG funding.


Tables 21 through 30 Information


  1. Pre-populated Data

CSAP and the states have agreed that the state-level reporting requirement for the NOMs listed in Tables 21-30 will be fulfilled through the use of extant data from sources including the National Survey on Drug Use and Health (NSDUH), the Fatality Analysis Reporting System (FARS) of the National Highway Traffic Safety Administration, the Uniform Crime Report (UCR) of the Federal Bureau of Investigation, and the National Center for Education Statistics (NCES) of the U.S. Department of Education. These pre-populated state-level NOMs will meet most of the state-level NOMs reporting requirements for the prevention portion of the SABG funding. These data will be pre-populated into the data tables by CSAP.


NOMs Domain - Reduced Morbidity Abstinence from Drug Use/Alcohol Use

  • Table 21: 30-Day Use

  • Table 22: Perception of Risk/Harm of Use

  • Table 23: Age of First Use

  • Table 24: Perception of Disapproval/Attitudes


NOMs Domain - Employment/Education

  • Table 25: Perception of Workplace Policy

  • Table 26: Average Daily School Attendance Rate


NOMs Domain - Crime and Criminal Justice

  • Table 27: Alcohol-Related Traffic Fatalities

  • Table 28: Alcohol- and Drug-Related Arrests NOMs Domain - Social Connectedness

50

  • Table 29: Family Communications Around Drug and Alcohol Use


NOMs Domain - Retention

  • Table 30: Youth Seeing, Reading, Watching, or Listening to a Prevention Message


In this block grant application, pre-populated data are automatically provided to fulfill the majority of the reporting requirements.


Territories and Native American tribes for which there are no NSDUH, FARS, UCR, and/or NCES data will not be required to report on those measures on those measures, but will be encouraged to provide substitute data in Column D.



  1. Supplemental Data

States may also wish to provide additional data related to the NOMs. The data can be included in the block grant appendix. When describing the supplemental data, states should provide any relevant Web addresses (URLs) that provide links to specific state data sources.


D. Instructions for Completing Forms

Column A: Measure - The SAMHSA-defined measure for the domain listed.

Column B: Question/Response

  • Source Survey Item: For Table 21-25, 29, and 30, the source is the NSDUH. For Tables 26-28 other "archival" sources are identified. The specific language used for each item is provided.

  • Response Option: The range of responses that are provided for the survey item.

  • Outcome Reported: The specific responses that are included in the calculation provided for the item.

  • Age: The age range for which the responses are provided.

Column C: Pre-populated Data - Pre-populated data are provided; see letter A, Pre-populated data.

Column D: Approved Substitute Data – Grantees for which there are no NSDUH, FARS, UCR and/or NCES data will be able to voluntarily enter data for the items in this column.

Substitute data is not allowed for grantees with pre-populated data.



51

SABG TABLE 21– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: REDUCED MORBIDITY - ABSTINENCE FROM DRUG USE/ALCOHOL USE

MEASURE: 30-DAY USE



A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemental Data, if any

1. 30-day Alcohol Use

Source Survey Item: NSDUH Questionnaire. “Think specifically about the past 30 days, that is, from [DATEFILL] through today. During the past 30 days, on how many days did you drink one or more drinks of an alcoholic beverage?” [Response option: Write in a number between 0 and 30.]

Outcome Reported: Percent who reported having used alcohol during the past 30 days.



Ages 12–20 CY 2016-2017



Ages 21+ - CY 2016-2017



2. 30-day Cigarette Use

Source Survey Item: NSDUH Questionnaire: “During the past 30 days, that is, since [DATEFILL], on how many days did you smoke part or all of a cigarette?” [Response option: Write in a number between 0 and 30.] Outcome Reported: Percent who reported having smoked a cigarette during the past 30 days.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



3. 30-day Use of Other Tobacco Products

Source Survey Item: NSDUH Questionnaire: “During the past 30 days, that is, since [DATEFILL], on how many days did you use [other tobacco products]?” [Response option: Write in a number between 0 and 30.]

Outcome Reported: Percent who reported having used a tobacco product other than cigarettes during the past 30 days, calculated by combining responses to questions about individual tobacco products (cigars, smokeless tobacco, pipe tobacco).



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



4. 30-day Use of Marijuana

Source Survey Item: NSDUH Questionnaire: “Think specifically about the past 30 days, from [DATEFILL] up to and including today. During the past 30 days, on how many days did you use marijuana or hashish?” [Response option: Write in a number between 0 and 30.]

Outcome Reported: Percent who reported having used marijuana or hashish during the past 30 days.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



5. 30-day Use of Illicit Drugs Other Than Marijuana

Source Survey Item: NSDUH Questionnaire: “Think specifically about the past 30 days, from [DATEFILL] up to and including today. During the past 30 days, on how many days did you use [any other illegal drug]?”

Outcome Reported: Percent who reported having used illegal drugs other than marijuana or hashish during the past 30 days, calculated by combining responses to questions about individual drugs (heroin, cocaine, hallucinogens, inhalants, methamphetamine, and misuse of prescription drugs).



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



NSDUH asks separate questions for each tobacco product. The number provided combines responses to all questions about tobacco products other than cigarettes.

NSDUH asks separate questions for each illegal drug. The number provided combines responses to all questions about illegal drugs other than marijuana or hashish.

SABG TABLE 22– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: REDUCED MORBIDITY - ABSTINENCE FROM DRUG USE/ALCOHOL USE

MEASURE: PERCEPTION OF RISK/HARM OF USE


A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemental Data, if any

1. Perception of Risk From Alcohol

Source Survey Item: NSDUH Questionnaire: “How much do people risk harming themselves physically and in other ways when they have five or more drinks of an alcoholic beverage once or twice a week?” [Response options: No risk, slight risk, moderate risk, great risk] Outcome Reported: Percent reporting moderate or great risk.



Ages 12–20 - CY 2016-2017



Ages 21+ - CY 2016-2017



2. Perception of Risk From Cigarettes

Source Survey Item: NSDUH Questionnaire: “How much do people risk harming themselves physically and in other ways when they smoke one or more packs of cigarettes per day?” [Response options: No risk, slight risk, moderate risk, great risk]

Outcome Reported: Percent reporting moderate or great risk.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



3. Perception of Risk From Marijuana

Source Survey Item: NSDUH Questionnaire: “How much do people risk harming themselves physically and in other ways when they smoke marijuana once or twice a week?” [Response options: No risk, slight risk, moderate risk, great risk]

Outcome Reported: Percent reporting moderate or great risk.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



SABG TABLE 23– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: REDUCED MORBIDITY - ABSTINENCE FROM DRUG USE/ALCOHOL USE

MEASURE: AGE OF FIRST USE


A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemental Data, if any

1. Age at First Use of Alcohol

Source Survey Item: NSDUH Questionnaire: “Think about the first time you had a drink of an alcoholic beverage. How old were you the first time you had a drink of an alcoholic beverage? Please do not include any time when you only had a sip or two from a drink.” [Response option: Write in age at first use.]

Outcome Reported: Average age at first use of alcohol.



Ages 12–20 - CY 2016-2017



Ages 21+ - CY 2016-2017



2. Age at First Use of Cigarettes

Source Survey Item: NSDUH Questionnaire: “How old were you the first time you smoked part or all of a cigarette?” [Response option: Write in age at first use.]

Outcome Reported: Average age at first use of cigarettes.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



3. Age at First Use of Tobacco Products Other Than Cigarettes

Source Survey Item: NSDUH Questionnaire: “How old were you the first time you used [any other tobacco product]?” [Response option: Write in age at first use.]

Outcome Reported: Average age at first use of tobacco products other than cigarettes.



Ages 12–17 - CY 2016-2017



Ages 18+ CY 2016-2017



4. Age at First Use of Marijuana or Hashish

Source Survey Item: NSDUH Questionnaire: “How old were you the first time you used marijuana or hashish?” [Response option: Write in age at first use.]

Outcome Reported: Average age at first use of marijuana or hashish.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



5. Age at First Use of Heroin

Source Survey Item: NSDUH Questionnaire: “How old were you the first time you used heroin?” [Response option: Write in age at first use.] Outcome Reported: Average age at first use of heroin.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



6. Age at First Misuse of Prescription Pain Relievers Among Past Year Initiates

Source Survey Item: NSDUH Questionnaire: “How old were you the first time you used [specific pain reliever] in a way a doctor did not direct you to use it?” [Response option: Write in age at first use.] Outcome Reported: Average age at first misuse of prescription pain relievers among those who first misused prescription pain relievers in the last 12 months.



Ages 12–17 - CY 2016-2017



Ages 18+ - CY 2016-2017



The question was asked about each tobacco product separately, and the youngest age at first use was taken as the measure.

The question was asked about each drug in this category separately, and the youngest age at first use was taken as the measure.

SABG TABLE 24– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: REDUCED MORBIDITY - ABSTINENCE FROM DRUG USE/ALCOHOL USE

MEASURE: PERCEPTION OF DISAPPROVAL/ATTITUDES


A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemental Data, if any

1. Disapproval of Cigarettes

Source Survey Item: NSDUH Questionnaire: “How do you feel about someone your age smoking one or more packs of cigarettes a day?” [Response options: Neither approve nor disapprove, somewhat disapprove, strongly disapprove]

Outcome Reported: Percent somewhat or strongly disapproving.



Ages 12–17 - CY 2016-2017



2. Perception of Peer Disapproval of Cigarettes

Source Survey Item: NSDUH Questionnaire: “How do you think your close friends would feel about you smoking one or more packs of cigarettes a day?” [Response options: Neither approve nor disapprove, somewhat disapprove, strongly disapprove]

Outcome Reported: Percent reporting that their friends would somewhat or strongly disapprove.



Ages 12–17 - CY 2016-2017



3. Disapproval of Using Marijuana Experimentally

Source Survey Item: NSDUH Questionnaire: “How do you feel about someone your age trying marijuana or hashish once or twice?” [Response options: Neither approve nor disapprove, somewhat disapprove, strongly disapprove]

Outcome Reported: Percent somewhat or strongly disapproving.



Ages 12–17 - CY 2016-2017



4. Disapproval of Using Marijuana Regularly

Source Survey Item: NSDUH Questionnaire: “How do you feel about someone your age using marijuana once a month or more?” [Response options: Neither approve nor disapprove, somewhat disapprove, strongly disapprove]

Outcome Reported: Percent somewhat or strongly disapproving.



Ages 12–17 - CY 2016-2017



5. Disapproval of Alcohol

Source Survey Item: NSDUH Questionnaire: “How do you feel about someone your age having one or two drinks of an alcoholic beverage nearly every day?” [Response options: Neither approve nor disapprove, somewhat disapprove, strongly disapprove]

Outcome Reported: Percent somewhat or strongly disapproving.



Ages 12–20 - CY 2016-2017



SABG TABLE 25– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: EMPLOYMENT/EDUCATION MEASURE: PERCEPTION OF WORKPLACE POLICY

A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemen tal Data, if any

Perception of Workplace Policy

Source Survey Item: NSDUH Questionnaire: “Would you be more or less likely to want to work for an employer that tests its employees for drug or alcohol use on a random basis? Would you say more likely, less likely, or would it make no difference to you?” [Response options: More likely, less likely, would make no difference]

Outcome Reported: Percent reporting that they would be more likely to work for an employer conducting random drug and alcohol tests.



Ages 15–17 - CY 2016-2017



Ages 18+ - CY 2016-2017




SABG TABLE 26– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: EMPLOYMENT/EDUCATION MEASURE: AVERAGE DAILY SCHOOL ATTENDANCE RATE

A.

Measure

B.

Source

C.

Pre- populated Data

D.

Supplemen tal Data, if any

Average Daily School Attendance Rate

Source: National Center for Education Statistics, Common Core of Data: The National Public Education Finance Survey available for download at http://nces.ed.gov/ccd/stfis.asp

Measure calculation: Average daily attendance (NCES defined) divided by total enrollment and multiplied by 100.



CY 2017




SABG TABLE 27 SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: CRIME AND CRIMINAL JUSTICE MEASURE: ALCOHOL-RELATED TRAFFIC FATALITIES

A.

Measure

B.

Source

C.

Pre- populated Data

D.

Supplemental Data, if any

Alcohol-Related Traffic Fatalities

Source: National Highway Traffic Safety Administration Fatality Analysis Reporting System

Measure calculation: The number of alcohol-related traffic fatalities divided by the total number of traffic fatalities and multiplied by 100.



CY 2017










SABG TABLE 28– SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: CRIME AND CRIMINAL JUSTICE MEASURE: ALCOHOL- AND DRUG-RELATED ARRESTS

A.

Measure

B.

Source

C.

Pre- populated Data

D.

Supplemental Data, if any

Alcohol- and Drug-Related Arrests

Source: Federal Bureau of Investigation Uniform Crime Reports Measure calculation: The number of alcohol- and drug-related arrests divided by the total number of arrests and multiplied by 100.



Forms P8 and P9 OMB No. 0930-0080




CY 2017



SABG TABLE 29 – SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: SOCIAL CONNECTEDNESS MEASURE: FAMILY COMMUNICATIONS AROUND DRUG AND ALCOHOL USE

A.

Measure

B.

Question/Response

C.

Pre- populated Data

D.

Supplemental Data, if any

1. Family

Source Survey Item: NSDUH Questionnaire: “Now think about the



Communications

past 12 months, that is, from [DATEFILL] through today. During

Around Drug and

the past 12 months, have you talked with at least one of your parents

Alcohol Use

about the dangers of tobacco, alcohol, or drug use? By parents, we

(Youth)

mean either your biological parents, adoptive parents, stepparents, or


adult guardians, whether or not they live with you.” [Response


options: Yes, No]


Outcome Reported: Percent reporting having talked with a parent.


Ages 12–17 - CY 2016-2017



2. Family

Source Survey Item: NSDUH Questionnaire: “During the past 12



Communications

months, how many times have you talked with your child about the

Around Drug and

dangers or problems associated with the use of tobacco, alcohol, or

Alcohol Use

other drugs?” [Response options: 0 times, 1 to 2 times, a few times,

(Parents of children

many times]

aged 12–17)

Outcome Reported: Percent of parents reporting that they have


talked to their child.


Ages 18+ - CY 2016-2017



NSDUH does not ask this question of all sampled parents. It is a validation question posed to parents of 12- to 17-year-old survey respondents. Therefore, the responses are not representative of the population of parents in a State. The sample sizes are often too small for valid reporting.


SABG TABLE 30 – SUBSTANCE ABUSE PREVENTION NOMS DOMAIN: RETENTION MEASURE: PERCENTAGE OF YOUTH SEEING, READING, WATCHING, OR LISTENING TO A

PREVENTION MESSAGE


Measure

Question/Response

Pre- populated Data

Supplemental Data, if any

Exposure to Prevention Messages

Source Survey Item: NSDUH Questionnaire: “During the past 12 months, do you recall [hearing, reading, or watching an advertisement about the prevention of substance use]?”

Outcome Reported: Percent reporting having been exposed to prevention message.



Ages 12–17 - CY 2016-2017



This is a summary of four separate NSDUH questions each asking about a specific type of prevention message delivered within a specific context

SABG Tables 31-35 Reporting Period


Reporting Period - Start and End Dates for Information Reported on SABG Tables 31, 32, 33, 34, and 35.


The following chart is for collecting information on the reporting periods for the data entered in Tables 31-35. Please note that the correct reporting period for Tables 31-34 is the Calendar Year (CY) which coincides with the reporting period for the pre-populated prevention NOMs in Tables 21-30. We understand that some states have reported on the state fiscal year (SFY) or federal fiscal year (FFY) for these tables in past SABG Reports. If your state is unable to report on the calendar year, please indicate in this footnote why you are unable to report on the calendar year and the steps the state intends to take to make calendar year reporting possible in future years. Note that the correct reporting period for Table 35 is the SABG compliance period that coincides with the reporting period for Tables 4, 5a, 5b, 6 and 7.


Rows 1 through 5 each correspond to a single form in the current year's application among the following five tables: 31, 32, 33, 34 and 35.

Column A: Enter the reporting period start date. Column B: Enter the reporting period end date.

The date format to be entered in columns A and B should be month/day/year, as follows.

  • Month: enter 2 digits (e.g. January = 01; December = 12)

  • Day: enter 2 digits (e.g. 1st of the month = 01; 15th of the month = 15)

  • Year: enter all 4 digits (e.g. 2012, 2013)


Reporting Period Start and End Dates for Information Reported on SABG Tables 31, 32, 33, 34 and 35

Please indicate the reporting period for each of the following NOMS.

Tables

A. Reporting Period Start Date

B. Reporting Period End Date

1. SABG Table 31

Individual-Based Programs and Strategies Number of Persons Served by Age, Gender, Race, and Ethnicity


mm/dd/yyyy


mm/dd/yyyy

2. SABG Table 32

Population-Based Programs and Strategies Number of Persons Served by Age, Gender, Race, and Ethnicity


mm/dd/yyyy


mm/dd/yyyy

3. SABG Table 33 (Optional)

Number of Persons Served by Type of Intervention


mm/dd/yyyy


mm/dd/yyyy

4. SABG Table 34

Number of Evidence-Based Programs and Strategies by Type of Intervention


mm/dd/yyyy


mm/dd/yyyy

5. SABG Table 35

Total Number of Evidence-Based Programs and Total SABG Dollars Spent on Evidence-Based Programs/Strategies



mm/dd/yyyy



mm/dd/yyyy

General Questions Regarding Prevention NOMS Reporting

Question 1: Describe the data collection system you used to collect the NOMs data (e.g., MDS, DbB, KIT Solutions, manual process).

Shape11


Question 2: Describe how your State’s data collection and reporting processes record a participant’s race, specifically for participants who are more than one race.

Indicate whether the State added those participants to the number for each applicable racial category or whether the State added all those participants to the More Than One Race subcategory.

Shape12


SABG Table 31 – SUBSTANCE ABUSE PREVENTION Individual-Based Programs and Strategies— Number of Persons Served by Age, Gender, Race, and Ethnicity

Category

Total

A. Age

0–4


5–11


12–14


15–17


18–20


21–24


25–44


45–64


65 and Over


Age Not Known


B. Gender

Male


Female


Gender Not Known



C. Ethnicity

Hispanic or Latino


Not Hispanic or Latino


Ethnicity Unknown


D. Race

White


Black or African American


Native Hawaiian/Other Pacific Islander


Asian


American Indian/Alaska Native


More Than One Race (not OMB required)


Race Not Known or Other (not OMB required)



SABG Table 32 – SUBSTANCE ABUSE PREVENTION Population-Based Programs and Strategies— Number of Persons Served by Age, Gender, Race, and Ethnicity


Category

Total

A. Age

0–4


5–11


12–14


15–17


18–20


21–24


25–44


45–64


65 and Over


Age Not Known


B. Gender

Male


Female


Gender Not Known


C. Race

White


Black or African American


Native Hawaiian/Other Pacific Islander


Asian


American Indian/Alaska Native


More Than One Race (not OMB required)


Race Not Known or Other (not OMB required)


D. Ethnicity

Hispanic or Latino


Not Hispanic or Latino


Ethnicity unknown


SABG Table 33 (Optional) SUBSTANCE ABUSE PREVENTION

Number of Persons Served by Type of Intervention






Intervention Type

Number of Persons Served by Individual- or Population-Based Program or Strategy

A.

Individual-Based Programs and Strategies

B.

Population-Based Programs and Strategies

1. Universal Direct



2. Universal Indirect



3. Selective



4. Indicated



5. Total



SABG Table 34 Substance Abuse Prevention

Evidence-Based Programs and Strategies by Type of Intervention

Definition of Evidence-Based Programs and Strategies: The guidance document for the Strategic Prevention Framework State Incentive Grant, Identifying and Selection Evidence-based Interventions, provides the following definition for evidence-based programs:

    • Inclusion in a Federal List or Registry of evidence-based interventions


    • Being Reported (with positive effects) in a peer-reviewed journal


    • Documentation of effectiveness based on the following guidelines:


      • Guideline 1: The intervention is based on a theory of change that is documented in a clear logic or conceptual model; and

      • Guideline 2: The intervention is similar in content and structure to interventions that appear in registries and/or the peer-reviewed literature; and

      • Guideline 3: The intervention is supported by documentation that it has been effectively implemented in the past, and multiple times, in a manner attentive to Identifying and Selecting Evidence-Based Interventions scientific standards of evidence and with results that show a consistent pattern of credible and positive effects; and

      • Guideline 4: The intervention is reviewed and deemed appropriate by a panel of informed prevention experts that includes: well-qualified prevention researchers who are experienced in evaluating prevention interventions similar to those under review; local prevention practitioners; and key community leaders as appropriate, e.g., officials from law enforcement and education sectors or elders within indigenous cultures.



Shape13


Shape14


SABG Table 34– SUBSTANCE ABUSE PREVENTION

Number of Evidence-Based Programs and Strategies by Type of Intervention




Number of Programs and Strategies by Type of Intervention

A.

Universal Direct

B.

Universal Indirect

C.

Universal Total

D.

Selective

E.

Indicated

F.

Total

1. Number of Evidence-Based Programs and Strategies Funded







2. Total number of Programs and Strategies Funded







3. Percent of Evidence-Based Programs and Strategies









SABG Table 35 – Total SUBSTANCE ABUSE PREVENTION Number of Evidence Based Programs/Strategies and Total SABG Dollars Spent on SUBSTANCE ABUSE PREVENTION Evidence- Based Programs/Strategies


Total Number of Evidence-Based Programs/Strategies for IOM Category below:


Total SAPT Block Grant $Dollars Spent on evidence-based Programs/Strategies


Universal Direct


Total #


$


Universal Indirect


Total #


$


Selective


Total #


$


Indicated


Total #


$


Unspecified


Total#


$



Total EBPs:


Total Dollars Spent: $










0 The 24-month expenditure period for the COVID-19 Relief supplemental funding is March 15, 2021 – March 14, 2023, which is different from the expenditure period for the “standard” SABG. Per the instructions, the “standard” SABG reporting period is state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. In this case, it is SFY 2021 (7/1/2020 – 6/30/2021). All expenditures made during SFY 2021 should be entered in Column H.

0 Prevention other than primary prevention

0 Only designated states as defined in 42 U.S.C. § 300x-24(b)(2) and 45 CFR § 96.128(b) for the applicable federal fiscal year should enter information in this row. This may include a state or states that were previously considered ?designated states? during any of the three prior federal fiscal years for which a state was applying for a grant. See EIs/HIV policy change in SABG Annual Report instructions.


0 The 24-month expenditure period for the COVID-19 Relief supplemental funding is March 15, 2021 – March 14, 2023, which is different from the expenditure period for the “standard” SABG. Per the instructions, the “standard” SABG reporting period is state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. In this case, it is SFY 2021 (7/1/2020 – 6/30/2021). All expenditures made during SFY 2021 should be entered here.



0 The 24-month expenditure period for the COVID-19 Relief supplemental funding is March 15, 2021 – March 14, 2023, which is different from the expenditure period for the “standard” SABG. Per the instructions, the “standard” SABG reporting period is state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. In this case, it is SFY 2021 (7/1/2020 – 6/30/2021). All person served using expenditures made during SFY 2021 should be entered in this table.

0

0 The 24-month expenditure period for the COVID-19 Relief supplemental funding is March 15, 2021 – March 14, 2023, which is different from the expenditure period for the “standard” SABG. Per the instructions, the “standard” SABG reporting period is state fiscal year immediately preceding the federal fiscal year for which the state is applying for funds. In this case, it is SFY 2021 (7/1/2020 – 6/30/2021). All admissions and persons served during SFY 2021 using the COVID-19 award should be entered in the appropriate column. If available, the related cost per person can be entered in the appropriate columns.

0 OUD Medication-Assisted Treatment Detoxification includes hospital detoxification, residential detoxification, or ambulatory detoxification services/settings AND Opioid Medication-Assisted Treatment.

0 OUD Medication Assisted Treatment Outpatient includes outpatient services/settings AND Opioid Medication-Assisted Treatment .



0 OUD Medication-Assisted Treatment Detoxification includes hospital detoxification, residential detoxification, or ambulatory detoxification services/settings AND Opioid Medication-Assisted Treatment.

0 OUD Medication Assisted Treatment Outpatient includes outpatient services/settings AND Opioid Medication-Assisted Treatment .




File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleTABLE 5A – Planned Primary Prevention Targeted Priorities – FY 2014
AuthorDHHS
File Modified0000-00-00
File Created2022-09-29

© 2024 OMB.report | Privacy Policy